Conference Call with Marksans Pharma Management and Analysts on Q3FY25 Performance and Outlook. Listen to the full earnings transcript.
Conference Call with Marksans Pharma Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.